Month: April 2025

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

Written by Customer Service on April 2, 2025. Posted in Public Companies.

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that management will present at the 24th Annual Needham Virtual Healthcare Conference, which is taking place from April 7-10, 2025, to discuss the company’s pipeline, platform, and business strategy. Participating will be Ben Zeskind, Chief Executive Officer, Brett Hall, Chief Scientific Officer, Igor Matushansky, Chief Medical Officer, Harold “E.B.” Brakewood, Chief Business Officer, Michael Bookman, Chief Legal Officer, Secretary and Mallory Morales, CPA, Chief Accounting Officer, Treasurer. Format: Company Presentation and 1×1 Investor Meetings Date/Time: April 9 from 1:30 – 2:10...

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share

Written by Customer Service on April 2, 2025. Posted in Mergers And Acquisitions.

SAN CARLOS, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Allakos Inc. (“Allakos”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today announced it has entered into a definitive merger agreement (the “Merger Agreement”) whereby Concentra Biosciences, LLC ( “Concentra”) will acquire Allakos for $0.33 in cash per share of Allakos common stock (“Allakos Common Stock”). Allakos’ Board of Directors has unanimously determined that the acquisition by Concentra is in the best interests of all Allakos shareholders and, following the unanimous recommendation of Allakos’ Transaction Committee, has approved the Merger Agreement and related transactions. Pursuant and subject to the terms of the Merger Agreement, a wholly owned subsidiary of Concentra...

UniFirst Announces Financial Results for the Second Quarter of Fiscal 2025

Written by Customer Service on April 2, 2025. Posted in Earnings Releases And Operating Results.

WILMINGTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its second quarter ended March 1, 2025 as compared to the corresponding period in the prior fiscal year: Q2 2025 Financial HighlightsConsolidated revenues for the second quarter increased 1.9% to $602.2 million. Operating income was $31.2 million, an increase of 11.7%. The quarterly tax rate decreased to 25.0% compared to 26.2% in the prior year. Net income increased to $24.5 million from $20.5 million in the prior year, or 19.6%. Diluted earnings per share increased to $1.31 from $1.09 in the prior year, or 20.2%. Adjusted EBITDA increased to $68.9 million compared to $64.8 million in the prior year, or 6.3%.The Company’s financial results for the second quarter of fiscal...

Superior Group of Companies’ Michael Benstock Featured on Smart Money Circle

Written by Customer Service on April 2, 2025. Posted in Public Companies.

ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) — — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman and Chief Executive Officer Michael Benstock was interviewed on the Smart Money Circle podcast, hosted by renowned investor Adam Sarhan. The interview is now available for viewing on the Smart Money Circle YouTube channel. Investors can also access the interview via Superior Group of Companies’ website at https://ir.superiorgroupofcompanies.com/presentations. About Superior Group of Companies, Inc. (SGC):Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary...

Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025

Written by Customer Service on April 2, 2025. Posted in Public Companies.

Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced that its President and CEO, Don Cilla, Pharm.D., M.B.A., will join Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”) Co-founder and CEO, Amro Albanna, for the Aditxt Weekly Update on April 4, 2025. The discussion will cover the Company’s recent operational highlights, including $117 million in new federal funding applications, and the status of the going-private transaction with Aditxt. Dr. Cilla will join Aditxt to...

VGP NV announces final results of its cash tender offer

Written by Customer Service on April 2, 2025. Posted in Public Companies.

PRESS RELEASE Regulated Information* Public disclosure of inside informationNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE “UNITED STATES”) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS PRESS RELEASE (SEE “OFFER AND DISTRIBUTION RESTRICTIONS” BELOW). THIS PRESS RELEASE RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE...

Heidmar Joins Nasdaq for Closing Bell

Written by Customer Service on April 2, 2025. Posted in Public Companies.

ATHENS, Greece and NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) — Heidmar Maritime Holdings Corp. (“Heidmar”) (NASDAQ: HMR), is pleased to announce that its senior leadership team will ring the Nasdaq Stock Market Closing Bell today at the Nasdaq MarketSite in Times Square, New York. Mr. Pankaj Khanna, CEO of Heidmar, commented: “We are honored to ring the Nasdaq Closing Bell in celebration of Heidmar’s strategic progress and the renewed momentum we are building across our platform.” The Closing Bell ceremony will be broadcast live on Wednesday, April 2nd, 2025 beginning at approximately 3:50 PM ET and can be viewed at: https://www.nasdaq.com/marketsite/bell-ringing-ceremony About Heidmar, Inc. Celebrating its 40th anniversary this year, Heidmar is an Athens based, commercial and pool management business servicing the crude and product...

Xeriant Appoints Acclaimed Nanomaterials Innovator Mark Sternberg to Board of Directors

Written by Customer Service on April 2, 2025. Posted in Public Companies.

Entering a Defining Moment in its Mission to Revolutionize Sustainable Building Materials BOCA RATON, Fla., April 02, 2025 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI) (“Xeriant” or “the Company”), dedicated to the discovery, development, and commercialization of disruptive technologies in advanced materials and aerospace, is proud to announce the appointment of Mark Sternberg to its Board of Directors. Mr. Sternberg brings an unparalleled track record of leadership in the field of nanotechnology and nanomaterial applications, including product development, manufacturing, licensing, marketing and sales. Among his many accomplishments was the successful positioning and sale of his company, Moyco Precision Abrasives, to Saint-Gobain, a $50B global leader in advanced materials for the industrial and construction...

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

Written by Customer Service on April 2, 2025. Posted in Public Companies.

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today reported preliminary unaudited cash for the fiscal year ending March 31, 2025, and net cash utilization results for the fiscal fourth quarter of 2025. The Company expects to release full fiscal second-quarter financial results the week of June 9-13, 2025. The Company also gave guidance that, as its common stock has been trading above the $1.00 minimum bid price required, it expects to meet the requirements for continued listing on the Nasdaq Capital Market should the closing price of its common stock remain at similar levels. Cash The Company’s preliminary cash and cash equivalents balance...

Provident Bank Elevates Tara Brady to Chief Experience Officer to Drive Customer Experience and Brand Growth

Written by Customer Service on April 2, 2025. Posted in Public Companies.

ISELIN, N.J., April 02, 2025 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based financial institution, is pleased to announce that Tara Brady has been promoted to Senior Vice President, Chief Experience Officer (CXO), responsible for leading the bank’s marketing and customer experience strategies, and ensuring seamless, customer-centric engagement across the organization. Ms. Brady will also focus on fostering deep collaboration and synergy between customer experience and employee experience. Since joining Provident, Ms. Brady has been instrumental in centralizing and enhancing the experience for customers. Her new role expands this work in support of the bank’s growth throughout the region.With a focus on delivering consistent and coordinated communications, and a unified brand identity, Ms. Brady will champion a...

Month: April 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals